TrialJournal of child and adolescent psychopharmacology2018

A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders.

Robert L Findling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.